EUVIMEDEUVIMED entdecken
Crossref

Curcumol Alleviates Ferroptosis in Metabolic‐Associated Fatty Liver Disease by Inhibiting EGFR –Endoplasmic Reticulum Stress Axis

Zhipeng Wang, Yansong Fu, Wenya Zheng iD, Xin Zeng, Zhuoya Xu, Jingmiao Chen, Xi Liu, Hong Qin iD

Phytotherapy Research · 2026-04 · 40 (4) · 1886-1902

DOI: 10.1002/ptr.70252 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 02.02.2026. Verfasst von Zhipeng Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Hygiene, Xiangya School of Public Health, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Sesquiterpenes, Endoplasmic Reticulum Stress, Ferroptosis, Fatty Liver. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province, Innovation-Driven Project of Central South University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatic ferroptosis has emerged as a crucial pathogenic mechanism and severe adverse outcome in metabolic‐associated fatty liver disease (MAFLD). Curcumol (CCM), a sesquiterpenoid phytochemical with potential hepatoprotective properties, remains unexplored for its therapeutic properties in MAFLD management. In this study, the effects and mechanisms of CCM on hepatic ferroptosis in MAFLD were investigated using in silico approaches and evaluated at the cellular and molecular levels using both in vivo and in vitro disease models of MAFLD. Our results showed that hepatic ferroptosis was accompanied by endoplasmic reticulum stress (ERS) in high‐fat‐induced MAFLD. Administration of the ERS inhibitor 4‐PBA significantly alleviated ferroptosis, suggesting the pathogenic role of ERS‐mediated ferroptosis in MAFLD. Notably, CCM exhibited comparable effects to 4‐PBA, indicating that CCM mitigated hepatic ferroptosis through inhibiting ERS. Subsequent data showed that the therapeutic effects of CCM were achieved by targeting epidermal growth factor receptor (EGFR), as evidenced by the phenomenon that the efficacy of CCM was reversed following the administration of an EGFR agonist. In conclusion, this study highlighted the therapeutic effects of CCM on alleviating hepatic ferroptosis in high‐fat‐induced MAFLD by inhibiting the EGFR–ERS axis, and emphasized the promising application of CCM in MAFLD management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SesquiterpenesEndoplasmic Reticulum StressFerroptosisFatty LiverAnimalsErbB ReceptorsHumansLiverMaleMiceDiet, High-Fat

Stichwörter der Autor:innen

Curcumolendoplasmic reticulum stressepidermal growth factor receptorferroptosismetabolic‐associated fatty liver disease

Substanzen

SesquiterpenesErbB Receptorscurcumol

Autor:innen und Institutionen

  • Department of Nutrition and Food Hygiene, Xiangya School of Public Health, Central South University, Changsha, Hunan, China.

ORCID-Profile: Wenya Zheng, Hong Qin

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hunan Province
  • Innovation-Driven Project of Central South University
  • Institute of Genetics
  • Chinese Academy of Sciences

Zitieren

APA

Wang, Z., Fu, Y., Zheng, W., Zeng, X., Xu, Z., Chen, J., Liu, X., & Qin, H. (2026). Curcumol Alleviates Ferroptosis in Metabolic‐Associated Fatty Liver Disease by Inhibiting EGFR –Endoplasmic Reticulum Stress Axis. Phytotherapy Research, 40(4), 1886-1902. https://doi.org/10.1002/ptr.70252

Vancouver

Wang Z, Fu Y, Zheng W, Zeng X, Xu Z, Chen J, et al. Curcumol Alleviates Ferroptosis in Metabolic‐Associated Fatty Liver Disease by Inhibiting EGFR –Endoplasmic Reticulum Stress Axis. Phytotherapy Research. 2026;40(4):1886-1902. doi:10.1002/ptr.70252

BibTeX
@article{Wang2026,
  author = {Wang, Zhipeng and Fu, Yansong and Zheng, Wenya and Zeng, Xin and Xu, Zhuoya and Chen, Jingmiao and Liu, Xi and Qin, Hong},
  title = {Curcumol Alleviates Ferroptosis in Metabolic‐Associated Fatty Liver Disease by Inhibiting EGFR –Endoplasmic Reticulum Stress Axis},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {4},
  pages = {1886--1902},
  doi = {10.1002/ptr.70252}
}
Kostenlos starten →